In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.
Pharmaceutical companies submit a TRIZIVIR Drug Master File in Korea (TRIZIVIR KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of TRIZIVIR. The MFDS reviews the TRIZIVIR KDMF as part of the drug registration process and uses the information provided in the TRIZIVIR KDMF to evaluate the safety and efficacy of the drug.
After submitting a TRIZIVIR KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their TRIZIVIR API can apply through the Korea Drug Master File (KDMF).
click here to find a list of TRIZIVIR suppliers with KDMF on PharmaCompass.